In an otherwise healthy 25-year-old pregnant woman with acute right hemiparesis and aphasia, last known well 3 hours ago, blood pressure 156/74 mm Hg, glucose 116 mg/dL, and only prenatal vitamin use, what is the most appropriate next step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 14, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the time window for intravenous (IV) thrombolysis using alteplase (tissue plasminogen activator) in a patient with acute basilar stroke?

What is the administration protocol for alteplase (tissue plasminogen activator) in patients with ischemic stroke?

What is the role of Alteplase (tissue plasminogen activator) in the management of acute ischemic stroke in adults?

What is the recommended administration and management of Alteplase (tissue plasminogen activator) for acute ischemic stroke?

When can antiplatelet therapy (e.g. aspirin or clopidogrel) be resumed in a patient with a cerebral infarct (stroke) who has been treated with alteplase (tissue plasminogen activator, tPA)?

Is Arnuity Ellipta (fluticasone furoate) an appropriate alternative to fluticasone propionate inhaler for a 15‑year‑old patient with asthma previously on fluticasone propionate HFA 44 µg twice daily?

What are the safest non‑pharmacologic and pharmacologic sleep aids for adults, including older adults and pregnant or breastfeeding patients?

What are the clinical differences between pathological and physiological neonatal jaundice, including onset, bilirubin levels, duration, associated symptoms, risk factors, causes, and management?

Is there any association between Wilms tumor and pyogenic granuloma?

What is a safe titration schedule to transition a patient on guanfacine extended‑release (Intuniv) 4 mg daily to low‑dose clonidine (Catapres) using doses lower than 0.1 mg, including how to taper guanfacine, increase clonidine, and monitor blood pressure and heart rate?

Should the patient be nil per os (NPO) before a magnetic resonance cholangiopancreatography (MRCP)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.